Home
Shop

STAVIR CAPSULE

COMPANY DISCLAIMER

Melon Globalcare are prominent exporters, wholesalers, and traders of Anti-Cancer and HIV Medicines. These products are acclaimed because of their accurate composition, excellent purity, easy to use, and longer shelf life. At the core of Melon Globalcare, we have a team of hardworking, passionate and professional workers. Our teams add extra efforts and courage to deliver excellent solution in work. They are self-motivated to set a new benchmark and to achieve perfection in their work. We can fulfil the need of bulk orders as we have a strong support of our vendors.

INTRODUCTION

Stavir (Stavudine40mg) Capsule belongs to a group of medicines called antiretrovirals. It is used to treat HIV (human immunodeficiency virus), the virus that can cause AIDS (acquired immunodeficiency syndrome). It helps to control HIV infection so your immune system can work better. This Capsule is not a cure for HIV or AIDS and only helps to decrease the amount of HIV in your body. This helps to lower your risk of getting HIV-related complications and improves your lifespan. It is prescribed in combination with other HIV medicines. Your doctor will recommend the best medicines for you and will decide the doses that you need. Follow carefully the instructions for all the medicines that you are given. It can be taken with or without food.

Taking all these medicines regularly at the right times greatly increases their effectiveness and reduces the chances of HIV becoming resistant to them.

Before taking it, tell your doctor if you have any skin problems or liver or kidney disease. While using it, you may need regular blood tests to check your blood counts and liver function. Avoid drinking alcohol as it may increase your risk of liver damage. Pregnant or breastfeeding mothers should consult their doctor before using this medicine. Do not have unprotected sex or share personal items like razors or toothbrushes, if you are HIV positive. Talk to your doctor about safe ways like condoms to prevent HIV transmission during sex.

HOW STAVIR CAPSULE WORK

Stavir 40mg Capsule is an antiviral medication. It prevents the multiplication of virus in human cells. This stops the virus from producing new viruses and clears up your infection.

USES OF STAVIR CAPSULE

HIV infection

BENEFIT OF STAVIR CAPSULE

Stavir 40mg Capsule is an antiretroviral medicine. It works by preventing the HIV virus from multiplying in your body. It helps control the infection and makes your immune system work better. This lowers your chances of getting complications such as new infections and improves your quality of life. This medicine is always taken in combination with other antiretroviral medicines.

It is not a cure for HIV or AIDS and should not be used to prevent HIV after accidental exposure to a risk. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor. Taking all doses in the right amount at the right times greatly increases the effectiveness of your combination of medicines and reduces the chances of your HIV infection becoming resistant to antiretroviral medicines. However, taking this medicine will not prevent you from passing HIV to other people.

SIDE EFEECT OF STAVIR CAPSULE

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.

 Comman Side Effect

  • Fatigue.
  • Headache.
  • Nausea.
  • Vomiting.
  • Stomach pain.
  • Diarrhea.
  • Rash.

SAFETY ADVISE

Caution is advised when consuming alcohol with Stavir Capsule. Please consult your doctor if you feel any symptoms after consuming. This Capsule may be unsafe to use during pregnancy. Although there are limited studies and have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. It is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Stavir Capsule is probably safe to use in patients with liver disease.

Limited data available suggests that dose adjustment of This Capsule may not be needed in these patients. Inform your doctor if you develop any signs and symptoms of jaundice while taking Stavir Capsule. You may need to stop taking this medicine. Stavir Capsule should be used with caution in patients with kidney disease. Dose adjustment of Stavir Capsule may be needed. This Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. It is advised not to drive if these symptoms occur. 

WHAT IS YOU FORGET TO TAKE TASVIR TABLET?

If you miss a dose of Stavir Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

VELPANAT TABLET

COMPANY DISCLAIMER

Melon Globalcare are prominent exporters, wholesalers, and traders of Anti-Cancer and HIV Medicines. These products are acclaimed because of their accurate composition, excellent purity, easy to use, and longer shelf life. At the core of Melon Globalcare, we have a team of hardworking, passionate and professional workers. Our teams add extra efforts and courage to deliver excellent solution in work. They are self-motivated to set a new benchmark and to achieve perfection in their work. We can fulfil the need of bulk orders as we have a strong support of our vendors.

  INTRODUCTION

Velpanat (Sofosbuvir 400mg and Velpatasvir 100mg) Tablet is a combination of two antiviral medicines. This prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection. Velpanat Tablet should be taken in the prescribed dose and duration. It can be taken with or without food, but take it at the same time daily. It is advised not to consume more than the recommended dose. It is important to inform your doctor if you have any health conditions such as liver or kidney disease. It is harmful to consume alcohol along with this medicine, so it is advised to limit or avoid alcohol. The course of the medicine should be completed for better results.

The common side effects of this medicine are tiredness and headache. You should drink plenty of fluid and eat a healthy diet to prevent or overcome the side effects. Before taking the medicine, inform your doctor if you are taking any other medicines or supplements.

 HOW TO USE VELPANAT TABLET

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Velpanat Tablet may be taken with or without food, but it is better to take it at a fixed time.

BENEFIT OF VELPANAT TABLET

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). When the infection moves into a long-lasting stage, it is called chronic hepatitis C virus infection. Velpanat Tablet helps reduce the number of hepatitis C virus by preventing it from spreading in your body. This helps control the infection and helps you recover faster. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor.

SIDE EFFECT OF VELPANAT TABLET

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Comman Side Effect Of Velpanat

  • Headache.
  • Tiredness.

SAFETY ADVICE

It is not known whether it is safe to consume alcohol with Velpanat Tablet. Please consult your doctor if you feel any symptoms after consuming. This tablet is safe to use in pregnancy and also while breastfeeding. Studies has shown no harmful effect on baby. It is also safe for patient having liver disease. Velpanat Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Velpanat Tablet may be needed. Limited information is available on the use of Velpanat Tablet in these patients.

No dose adjustment is recommended in patients with mild to moderate kidney disease. This tablet may cause side effects which could affect your ability to drive. Velpanat Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive. It is advised not to drive after taking this medicine.

WHAT IF YOU FORGET TO TAKE VELPANAT TABLET

If you miss a dose of Velpanat Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

5 Reasons Life Sciences Needs Better Clinical Trial Supply Management

COMPANY DISCLAIMER

Melon Globalcare are prominent exporters, wholesalers, and traders of Anti-Cancer and HIV Medicines. These products are acclaimed because of their accurate composition, excellent purity, easy to use, and longer shelf life. At the core of Melon Globalcare, we have a team of hardworking, passionate and professional workers. Our teams add extra efforts and courage to deliver excellent solution in work. They are self-motivated to set a new benchmark and to achieve perfection in their work. We can fulfil the need of bulk orders as we have a strong support of our vendors.

INTRODUCTION

COVID-19 has upended clinical trials. Across the world enrollment is down and supply logistics are unstable and new virtual business processes emerge. The instability is shining a bright light on clinical trial supply management, exposing what is working and the clear, undeniable weaknesses. Unfortunately, the familiar manual processes and the usual customer-individual approaches to clinical trial supply management (CTSM) are proving difficult to maintain.

The gaps in CTSM are impossible to ignore in a world eagerly awaiting new medical treatments. An exciting positive is that heightened awareness could usher in a better option.

Similar to the industry 4.0 efforts on the manufacturing side, efforts to create a next-generation clinical trial supply chain are not only possible, but required and already underway. Life science leaders are building a consortium to shape the future of clinical supplies operations and develop industry best practices. The goal is to improve key clinical supplies processes for the life sciences industry, like clinical supplies cycle time, transparency into the demand and dispensation of clinical supplies, reduction of materials going to waste and higher process automation to reduce effort and cost.

Built on advanced intelligent technologies, the next-generation CTSM solution merges cloud capabilities, deployment flexibility and an integrated demand forecast with modern manufacturing, packaging, labeling, and supply chain functionalities to benefit from innovations on the commercial side also for clinical supplies processes. Combining these technologies means that stakeholders can base their supply and demand decisions on clinical trial parameters such as planned and active enrollment rates, shelf life, clinical site replenishment algorithms and capacity and logistics constraints.

Within the consortium’s vision, a CTSM built on today’s most advanced technologies can help address these five clinical trial supply chain main points.

Industry dilemma 1: Lack of transparency increases costs and hinders collaboration.


A CTSM industry solution ensures much-needed transparency that will:

1. Provide end-to-end insight into supplies demand and ensures optimal amount of stock at site.
2. Assess the speed of planned enrollment and length of each individual treatment to plan for supplies needed in countries and clinical sites where clinical trials will be conducted.
3. Support comparisons of planned versus actual enrollment and learnings from earlier clinical trial stages or other clinical trials to improve supplies demand predictions.
4. Track clinical supplies from source to clinical site with accurate, trustworthy data to ensure optimal patient treatment.
5. Improve collaboration with external partners and all stakeholders by enabling real-time data exchange for supply chain visibility.

Industry dilemma 2: Inflexible business processes make it difficult to fulfill clinical supplies needs


A highly flexible CTSM industry solution will:


1. Address future clinical supplies business needs and accommodate various types of clinical trials.
2. Facilitate master data set-up.
3. Lower integration effort.
4. Increase collaboration with other clinical trial stakeholders.
5. Reduce supply cycle times from manufacturing to patient to help accommodate new business processes.

Industry dilemma 3: Stock overages lead to increased costs and waste.


A CTSM industry solution will minimize stock overages and labor cost as it:

1. Reduces unnecessarily high inventory levels through more accurate planning.
2. Reduces supplies overage/buffers through avoidance of static reservations per trials and pooling of supplies.
3. Leverages additional sources of information to apply up-front knowledge, for example from treatment and dispensing insights, from in-transit stock, from planned/in-process orders, and from IoT clinical supplies tracking.
4. Enables cross-trial planning and planning on API/substance level.
5. Minimizes manual recall, re-label and reconciliation efforts.

Industry dilemma 4: High cost of ownership prevents innovation.


A CTSM industry solution will reduce total cost of ownership as it:

1. Leverages innovations from a commercial intelligent suite.
2. Eliminates error-prone manual processes and reduces complexity.
3. Introduces a more cost-effective option than customer-individual CTSM approaches.
4. Ensures latest technology advancements through planned and continuous software release cycles.
5. Harmonizes the corporate system landscape.

Industry dilemma 5: Non-compliance risks can prevent drug treatments from entering market.

To reduce non-compliance risks, a CTSM industry solution will:

1. Support drug accountability and automated reconciliation processes.
2. Enforce process compliance.
3. Stay up to date with statutory and regulatory requirements.
4. Share best practices across all stakeholders.

An integrated, proactive CTSM solution can greatly improve the management of clinical supplies, while addressing the special needs for blinding, collaboration and tracking of supplies in a clinical trial setting. When analytics, intelligent data management, and an integrated information flow logic beyond corporate boundaries are coming together. Supply chain stakeholders can make smarter decisions about manufacturing, packaging, and delivering clinical trial materials across the globe.

The time is ripe for improving clinical supplies operations and processes that no longer serve today’s life sciences industry’s needs.

DEGRINTA INJECTION

COMPANY DISCLAIMER

Melon Globalcare are prominent exporters, wholesalers, and traders of Anti-Cancer and HIV Medicines. These products are acclaimed because of their accurate composition, excellent purity, easy to use, and longer shelf life. At the core of Melon Globalcare, we have a team of hardworking, passionate and professional workers. Our teams add extra efforts and courage to deliver excellent solution in work. They are self-motivated to set a new benchmark and to achieve perfection in their work. We can fulfil the need of bulk orders as we have a strong support of our vendors.

INTRODUCTION

Degrinta 80mg Injection is used in the treatment of advanced prostate cancer. It works by lowering the amount of testosterone produced in the body and restricts the growth of a cancer cell. Degrinta 80mg Injection is given as an injection under the skin only under the supervision of a doctor.  Do not try to self inject the medicine as it might enhance the chances of an accident or get injected into the veins. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. You should take this medicine for as long as it is prescribed for you.

PRECAUTIONS BEFORE TAKING DEGRINTA INJECTION

Before taking this medicine, tell your doctor if you have ever had heart disease, or diabetes or liver disease. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Tell your doctor if you are pregnant or breastfeeding. Your doctor may check for prostate specific antigen (PSA) level in your blood, to know treatment is working or not.

HOW TO USE DEGRINTA INJECTION

Your doctor or nurse will give you this medicine. Kindly do not self administer.

BENEFIT OF DEGRINTA INJECTION

Prostate gland is a small walnut-sized gland that produces a fluid called seminal fluid that nourishes and transports sperms in males. The most common symptom of prostate cancer is difficulty with urination, but sometimes there are no symptoms at all. Degrinta 80mg Injection decreases or stops the growth of cancer cells by decreasing the amount of testosterone (natural hormone in males) in men. This also relieves difficulty in passing urine and makes it easier for you to urinate.

SAFETY ADVICE

Caution is advised when consuming alcohol with Degrinta Injection. Please consult your doctor if you feel any kind of symptoms after consuming. This Injection is highly unsafe to use during pregnancy. Seek your doctor’s advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby. It is also unsafe for driving as may affect your driving and you may feel decrease in alertness, affect your vision or make you feel dizzy and sleepy. It is advised to not drive after taking this injection. There is limited information available on the use of Degrinta Injection in patients with kidney disease.

A cautious use of Degrinta 80mg Injection is advised in patients with severe kidney disease. This Injection should be used with caution in patients with severe liver disease. Dose adjustment of Degrinta 80mg Injection may be needed. No dose adjustment is recommended for patients with mild to moderate liver disease. Regular monitoring of testosterone levels is advised.

SIDE EFFECT OF DEGRINTA INJECTION

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

COMMAN SIDE EFFECT OF DEGRINTA INJECTION          

  • Injection site reactions (pain, swelling, redness).
  • Weight gain.
  • Hot flashes.
  • Increased liver enzymes.
  • Low sexual desire.
  • Erectile dysfunction.

Scope Of Third Party Manufacturing In Mumbai

                 COMPANY DISCLAIMER

Melon Globalcare are prominent exporters, wholesalers, and traders of Anti-Cancer and HIV Medicines. These products are acclaimed because of their accurate composition, excellent purity, easy to use, and longer shelf life. At the core of Melon Globalcare, we have a team of hardworking, passionate and professional workers. Our teams add extra efforts and courage to deliver excellent solution in work. They are self-motivated to set a new benchmark and to achieve perfection in their work. We can fulfil the need of bulk orders as we have a strong support of our vendors.

THIRD PARTY MANUFACTURNG COMPANIES IN MUMBAI

Mumbai is the capital of Maharashtra and the global pharmaceutical leader and the world’s largest generic medicines producer. A medicine manufacturing company in Mumbai is committed to improving the quality of health solutions worldwide. Over 80 percent of pharma manufacturers companies delivering the world’s largest medicine producer to 200+ million people every day. They provide healthcare research-based solutions and increasing access to quality health solutions globally. They are one of the best market leaders in the pharmaceutical industry worldwide.

SCOPE OF THIRD PARTY MANUFACTURING IN MUMBAI

3. Quality assurance & lab testing.

4. Introduce new and innovative product.

There are a lot of benefits of contract manufacturing services in Mumbai as they are using HIFI-technology in the production of medicines and they research to maintain the quality of products and improve the effectiveness of the pharma products which are hygiene, safe and affordable in price.

1. Hi-tech machinery and devices for improving pharma products.

2. High quality based product packaging with good designs.

LIST OF PHARMA MANUFACTURING COMPANIES

1. Agio Pharmaceuticals Ltd.

Agio Pharmaceuticals limited company was established in 1991 provides third party pharma manufacturers in Mumbai. The company understanding the strategic & operationa l needs of customers along with planning for each country to give them support in the areas of ethical & OTC medicines, herbal formulations, and veterinary products. Their products manufactured by who GMP approved. They understand the requirement of the customers by offering safe and hygiene product quality every time they give third party manufacturing services to deliver good quality to our esteemed customers.

They will provide healthcare solutions with the maintenance of the highest ethical standards through our passion for excellence and unwavering commitment.

2. Ishita Pharma

Ishita pharma has more than 17 years of product quality experience, they are distributing and exporting pharmaceutical products in a broad manner. They have an extensive range of generic pharmaceutical products, human vaccines & pharmaceutical products oncology (anti-cancer) products, and surgical care products. Our products are known for their hygiene, safe and effective with fewer side effects. They believe in customer satisfaction to provide the best quality of pharmaceutical products at a very affordable price. They are manufacturers, warehousing, distribution, and sales. They have successfully served clients spread across in the market of Caribbean, African, Latin American, Southeast Asia, and Middle East countries.

3. Influx Healthcare

Influx healthcare started in 2003 in Mumbai. It is one of the fastest-growing third party pharma manufacturers in Mumbai. It is certified by GMP and ISO 22000 with well-equipped devices, quality control department, and competent manpower. They have a pan India based clients and a wide range of presence in 4 continents. Their main business involves third party manufacturing, marketing, contract manufacturing, and supplements. They have a wide distributor of networks.

4. Biobaxy Technologies

Biobaxy technologies India provides third party pharma manufacturers in Mumbai which is established in many parts of the globe deals with multiple branches, retail, wholesale and outlets. The company involves in manufacturing & exporting of a high-quality range of herbal, food and pharma products, it is a trusted healthcare industry which is 100% export-oriented iso-9001-2008 GMP & FSSAI approved. Biobaxy technologies are authorized by the FDA in India which is having the retail/wholesale sector. They have a large number of clients in different locations worldwide. They have a team of experts who are formulated in the range of cosmetic and pharma products by providing high-quality services to their customers. 

Hepatitis C Treatment Has Changed Dramatically Throughout The Years.

Since HEPATITIS C was discovered in 1989, the pharmacological management of infections caused by the virus has undergone some revolutionary changes, significantly improving cure rates and reducing patient morbidity and mortality. Previously people diagnosed with hepatitis C would be faced with 24-48 weeks of treatment that was, at best, difficult for most patients to complete and, at worst, impossible to complete for others.

The treatment combined two drugs interferon and ribavirin, which were accompanied by a laundry list of side effects so significant that counselling of patients’ loved ones was often necessary.

There is still no vaccine for hepatitis C and people can contract hep C more than once. According to Health Canada, it’s estimated that 170 million individuals are infected worldwide, including about 250,000 Canadians. Hepatitis C is spread through contact with infected blood.

Patients with mental illness were not offered treatment due to the possibility that treatment could actually worsen their mental illness. Generally, patients who did receive treatment suffered through physical and emotional side effects despite knowing that the successful cure rate was just 40-60%. Now, fast forward to present day, and advancements in treatment for hep C patients allow for a much more positive outlook in their battle against the disease, with new hepatitis treatments curing 90-95% of patients.

In 2011 the first direct-acting antiviral agents were introduced and since have continued to improve both the efficacy and tolerability of treatment. The development of the direct-acting antiviral agents has reduced disease burden, expanded treatment options for patients with different hepatitis C genotypes or other pre-existing comorbidities, and significantly improved cure rates, which now exceed 95% with newer antiviral agents.

Barriers to using this therapy in British Columbia include suboptimal population screening and diagnosis, variable patient and physician knowledge, high drug costs, lack of insurance coverage for some antivirals, and difficulty accessing coverage under Pharmacare. Re-infection is also an ever-present risk. Using the antiviral therapies currently available and ensuring patients have better access to care would make eliminating hepatitis C possible in British Columbia, especially if health care providers, patient communities, and government agencies all strive to achieve this goal.  

WHAT IS THIRD PARTY MANUFACTURING AND IT’S BENEFITS?

Third-party is not a new concept, all companies get manufactured their products from other companies and Pharma companies are no exception to this practice. The third party pharma manufacturing concept is highly acceptable in the pharmaceutical Industry these days. The Pharma Third Party Manufacturing as the name suggests is a process in which a company gets manufactured its products from other party. Third party manufacturers are likewise also known as Contract Manufacturing Organization (CMO) and it is also known and contract development and manufacturing organization (CDMO). We can define Third Party manufacturing as Creation of products by one firm, under the name or brand of another firm.

As the world of drug manufacturing grows more complex and expensive, and keeping up with tight manufacturing deadlines becomes more challenging than ever before, many pharmaceutical companies are exploring the advantages of outsourcing drug manufacturing processes which is known as third party contract manufacturing.

What Is Third Party Manufacturing & It’s Benefits.

There is an agreement signed between the company and the manufacturing company and the manufacturing company manufactures the products as per the contract so the third party manufacturing Pharma process is also called contract manufacturing. This contract can be for one time, for a specified period or it may be a lifetime contract. This business practice involves the hiring of qualified third parties to perform functions that the manufacturer may not have the time, space, equipment or expertise to handle in-house production.

Many pharma companies now offer third party manufacturing service because it has may benefit to offer to both the customers and the company getting the service. It is a term used when a pharma company gets products manufactured at customized conditions. For example, it provides the raw material, packaging material, or other things necessary for production. The manufacturer assembles the things. Normally, large companies use this business model. The company manufacturer commits to provide products on the decided date.

Benefits Of Third Party Manufacturing

  • Cost-effective production.
  • Quality of production.
  • Business expansion at lesser investment.
  • It is a win-win situation for you and the pharma company.
  • Professional experience.
  • Higher efficiency.

Named Patient Program (NPP)

Named Patient Program (NPP) provide controlled, pre-approval access to drugs in response to requests by physicians on behalf of specific, or “named”, patients before those medicines are licensed in the patient’s home country. Through these programs, patients are able to access drugs in late-stage clinical trials or approved in other countries for a genuine, unmet medical need, before those drugs have been licensed in the patient’s home country.

Named Patient Program (NPP) provide controlled, pre-approval access to drugs in response to requests by physicians on behalf of specific, or “named”, patients before those medicines are licensed in the patient’s home country. Through these programs, patients are able to access drugs in late-stage clinical trials or approved in other countries for a genuine, unmet medical need, before those drugs have been licensed in the patient’s home country.

What is Named Patient Program (NPP)?

It is common in certain cases, that drugs are already discovered, but not marketed in every global region due to ongoing approval processes or products are under the late-stage of clinical research. Named Patient Program breaks the gap between such medication accessibility to physicians and patients. Named Patient Program gives the freedom to the physician to prescribe medication that is available in well-established pharma- markets. Both physicians and patients can order these medications by providing necessary documentation required to prove the actual need of the drug/s.

Named Patient Program has the accessibility to all well-established pharma- markets and sponsors for sourcing the necessary medications. Named Patient Program brings the global marker under one umbrella for physicians, patients as well as for sponsors. Named Patient Program maintains all the regulatory and logistics requirements to provide hassle-free service to all the consumers.

Uses Of Named Patient Program

Named Patient Program is useful for all the pharma sponsors also. Usually, sponsors want to launch their products in the popular markets where they get more patients and well-established pharma markets of the USA, Europe, and Japan or other such vast markets. But Name Patient Program gives them a scope to market their products beyond commercialization.

The patient from any country who is recognized as ‘the Named Patient’ and suffering from the chronic, serious, or life-threatening disease has the right to access, procure, and import medicines which have life-saving potentiality or improve the quality of life of the patient. But rules and regulations for importing innovative medications are different in every country. Every country has to follow its own regulation to import such medications.  Different programs are already existed such as Named Patient Import, Early Access Program, and Compassionate Use Program specifically available to import such medications. However, every country follows its own program.

A Named Patient Program (NPP) provides patients and physicians access to commercially approved medicines that are not available to them in their own country. These drugs must be approved in at least one country, from which it can be imported into the patient’s country under NPP.

These may be drugs that are:

  • Approved but not yet commercially available to be prescribed in the patient’s country.
  • Approved and available in one country but not approved and available in the patient’s country.
  • Discontinued in the patient’s country but not another.
  • In shortage in the patient’s country but not another.
Back to Top
Product has been added to your cart